The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD)

Transfusion and Apheresis Science

Volumn 36, Issue 1, 2007, Pages 79-85

  Ayyildiz, Erol ^a   Arslan, Önder ^a   Topçuoǧlu, Pervin ^a   Arat, Mutlu ^a   Dalva, Klara ^a   Soydan, Ender A ^a   Tol, Meltem ^a   Ilhan, Osman ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Extracorporeal photoimmunotherapy (ECP); Graft versus host disease (GvHD); Tumor necrosis factor (TNF)

Indexed keywords

CYCLOSPORIN A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD SAMPLING; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL PHOTOIMMUNOTHERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOTHERAPY; MALE;

ADULT; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PHOTOTHERAPY; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847414115     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.06.007     Document Type: Article

References (20)

1. Ferrara J.L., and Deeg H.J. Graft versus host disease. N Engl J Med 324 10 (1991) 667-674
2. Antin J.H., and Ferrara J.L. Cytokine dysregulation and acute graft versus host disease. Blood 80 12 (1992) 2964-2968
3. Atkinson K. Chronic graft versus host disease. Bone Marrow Transplant 5 (1990) 90
4. Margolis J., and Vogelsang G. Chronic graft versus host disease. J Hematother Stem Cell Res 9 3 (2000) 339-346
5. Slavin S., Nagler A., Naparstek E., Kapelushnik Y., Aker M., Cividalli G., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91 (1998) 756-763
6. Beatty P.G., Hansen J.A., Longton G.M., et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51 (1991) 443-447
7. Storek J., Gooley T., Siadak M., et al. Allogeneic peripheral stem cell transplantation may be associated with a high risk of chronic graft versus host disease. Blood 90 (1997) 4705-4709
8. Vilcek J., and Lee T.H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem (1991) 266
9. Beutler B.A., Milsark J.W., and Cerami A. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 135 (1985) 3972-3977
10. Billingham R.E. The biology of graft versus host reactions. Harvey Lect 62 (1966-67) 21-78
11. Allen R.D., Staley T.A., and Sidman C.L. Differential cytokine expression in acute and chronic murine graft versus host disease. Eur J Immunol 23 (1993) 333-337
12. Edelson R., Berger C., Gasparro F., Jegaothy B., Heald P., Wintroub B., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 316 (1987) 297-303
13. Edelson R.L. Transimmunization: science catches up to the clinical success. Transfus Apher Sci 26 (2002) 177-180
14. Yoo E.K., Rook A.H., Elenitsas R., et al. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance tomechanism of therapeutic action. J Invest Dermatol 107 (1996) 235-242
15. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus Apher Sci 29 (2003) 61-70
16. Foss F.M., Gorgun G., and Miller K.B. Extracorporeal photopheresis in chronic graft versus host disease. Bone Marrow Transplant 29 (2002) 719-725
17. Vowels B.R., Cassin M., Boufal M.H., et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 98 (1992) 686-692
18. Richardson S.K., McGinnis K.S., Shapiro M., Lehrer M.S., Kim E.J., Vittorio C.C., et al. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma. J Cutan Med Surg 7 suppl (2003) 8-12
19. Bladon J., and Taylor P.C. Extracorporeal photopheresis reduces the number of mononucleer cells that produce pro-inflammatory cytokines when tested ex-vivo. J Clin Apheresis 17 (2002) 177-182
20. Rosseti F., Zullian F., Dall'Amico R., et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft versus host disease. Transplantation 59 (1995) 149-151